Skip to main content
. 2024 Jul 22;115(10):3384–3393. doi: 10.1111/cas.16281

FIGURE 4.

FIGURE 4

Overall survival. (A) Overall survival (OS) for all 92 eligible patients. The 2‐year OS was 98.9% in the 92 eligible patients. (B) OS for 19 interim PET‐positive patients. The 2‐year OS was 94.7% in the 19 interim PET‐positive patients. (C) OS for 73 interim PET‐negative patients. The 2‐year OS was 100% in 72 interim PET‐negative patients.